Simran Ochani

Cardioembolic stroke risk in hypertrophic cardiomyopathy: role of anticoagulation—a systematic review

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by myocardial hypertrophy, diastolic dysfunction, and a high risk of atrial fibrillation (AF) and stroke. AF is the most common arrhythmia in HCM and a key driver of cardioembolic events. However, anticoagulati...